Amikacin Sulfate Injection, Solution
Product Images NDC 63323-815

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amikacin Sulfate (NDC 63323-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ami0b 0000 01

FDA Label Image

Ami0b 0000 02

FDA Label Image

Ami0b 0000 03

Ami0b 0000 03
This is a description of Amikacin Sulfate Injection, USP, which is available in a single dose vial containing 500 mg per 2 mL (50 mg per mL). It is used for intramuscular or intravenous administration. The product contains 20 myambutol equivalents of Amikacin Sulfate, 5K of sodium metabisulfite, and 45W of hydrochloric acid to adjust pH. The recommended dosage for adults is based on body weight and should not exceed 15 mg per kg per day. The drug should be stored at a temperature between 20°C and 25°C. The manufacturer is Fresenius Kabi.*
FDA Label Image

Ami0b 0000 04

Ami0b 0000 04
Amikacin Sulfate Injection, USP is a medication that contains 500mg per 2mL (250mg per mL) of the active ingredient amikacin sulfate. It is used to treat a variety of bacterial infections. The meaning of "i e i ki" is not clear and may be a result of error.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.